Related Experiment Video
Updated: Jan 6, 2026

Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice
Published on: November 27, 2019
Effect of fasting duration on mortality after COVID-19 infection: A retrospective analysis at a single institution
Naoko Takaku1,2, Koji Hayashi1, Hiromi Hayashi1
1Department of Rehabilitation Medicine, Fukui General Hospital, Fukui 9108561, Japan.
Background:
The fasting duration in aspiration pneumonia negatively affects the patient's treatment duration and swallowing function. The relationship among serious COVID-19 infection, fasting duration, and patient prognosis remains unclear. We aimed to determine the effect of the fasting duration on mortality after COVID-19.
Methods:
We included patients who underwent rehabilitation after COVID-19 infection between March 1, 2021 and June 30, 2023. We retrospectively extracted data from medical records, including age, sex, albumin levels, fasting duration, Charlson Comorbidity Index (CCI), Revised Hasegawa Dementia Scale score, care level, total hospitalization period, time since disease onset, time to speech therapy intervention, time to death, and ability to eat at disease onset and discharge. Univariate analysis was conducted for each variable. To investigate the relationship between fasting duration and outcomes, we performed logistic regression analysis, adjusting for confounding factors such as age, CCI, and care level. We also divided patients into groups based on fasting duration: ≤ 5 days and > 5 days. We performed logistic regression analysis using fasting duration as the dependent variable and age, CCI, care level, and clinical outcome as independent variables.
Results:
There were 71 patients in the survival group and 31 in the mortality group. Fasting duration (p = 0.00826, odds ratio [OR]: 1.01, 95 % confidence interval [CI]: 1.01-1.11) and age (p = 0.0377, OR: 1.07, 95 % CI: 1.001-1.15) were significant independent factors associated with COVID-19 outcomes. In the classification based on fasting duration, higher care level (p < 0.001, OR: 1.65, 95 % CI: 1.24-2.20) and clinical outcome (p < 0.001, OR: 9.19, 95 % CI: 2.80-30.20) were significant independent factors in the group with fasting duration > 5 days.
Conclusion:
Fasting duration was independently associated with outcomes after COVID-19 infection. Early rehabilitation intervention may contribute to improved clinical outcomes.
Related Concept Videos
Metabolic States of the Body: Fasting and Starvation
Metabolic States of the Body: The Postabsorptive State
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
Bioavailability Study Design: Healthy Subjects Versus Patients
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Censoring Survival Data
